Targeting angiogenesis for controlling neuroblastoma

Journal of Oncology

Volumn , Issue , 2012, Pages

  Ray, Swapan K ^a   Roy Choudhury, Subhasree ^a   Karmakar, Surajit ^a   Banik, Naren L ^b  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5 (2,6 DICHLOROBENZYLSULFONYL) 3 [3,5 DIMETHYL 4 [2 (1 PYRROLIDINYLMETHYL) 1 PYRROLIDINYLCARBONYL] 1H PYRROL 2 YLMETHYLENE] 1,3 DIHYDRO 2H INDOL 2 ONE; 6 (2,6 DICHLOROPHENYL) 2 (4 FLUORO 3 METHYLANILINO) 8 METHYL 8H PYRIDO[2,3 D]PYRIMIDIN 7 ONE; BEVACIZUMAB; BORTEZOMIB; CE 3556221; CEDIRANIB; CISPLATIN; CRIZOTINIB; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE INHIBITOR; ENDOSTATIN; EZN 2208; FLT3 LIGAND; FORETINIB; FUMAGILLOL CHLOROACETYLCARBAMATE; IMATINIB; INTEGRIN; MATRIX METALLOPROTEINASE; N (3 CHLOROPHENYL) 3 [3,5 DIMETHYL 4 (4 METHYL 1 PIPERAZINYLCARBONYL) 1H PYRROL 2 YLMETHYLENE] 2,3 DIHYDRO N METHYL 2 OXO 1H INDOLE 5 SULFONAMIDE; NEUROTROPHIN; OA 5D5; ORANTINIB; OSTEOPONTIN; PACLITAXEL; PEGAPTANIB; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; RILOTUMUMAB; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; XL 184;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER COMBINATION CHEMOTHERAPY; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; FLOW CYTOMETRY; GENE THERAPY; HUMAN; IMMUNOTHERAPY; MALIGNANT NEUROBLASTOMA; METASTASIS; MONOTHERAPY; NEUROBLASTOMA; NONHUMAN; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 80053495098     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/782020     Document Type: Review

References (104)

1. Hiyama E., Iehara T., Sugimoto T., Fukuzawa M., Hayashi Y., Sasaki F., Sugiyama M., Kondo S., Yoneda A., Yamaoka H., Tajiri T., Akazawa K., Ohtaki M., Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study The Lancet 2008 371 9619 1173 1180 (Pubitemid 351458522)
2. Ogawa S., Takita J., Sanada M., Hayashi Y., Oncogenic mutations of ALK in neuroblastoma Cancer Science 2011 102 2 302 308
3. Rssler J., Monnet Y., Farace F., The selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor activity in human neuroblastoma xenografts International Journal of Cancer 2011 128 11 2748 2758
4. Fox S. B., Gasparini G., Harris A. L., Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs Lancet Oncology 2001 2 5 278 289 (Pubitemid 33591566)
5. Herman I. M., Nussenbaum F., Tumor angiogenesis: insights and innovations Journal of Oncology 2010 2010
6. Oklu R., Walker T. G., Wicky S., Hesketh R., Angiogenesis and current antiangiogenic strategies for the treatment of cancer Journal of Vascular and Interventional Radiology 2010 21 12 1791 1805
7. Lyons J. 3rd, Anthony C. T., Woltering E. A., The role of angiogenesis in neuroendocrine tumors Endocrinology and Metabolism Clinics of North America 2010 39 4 839 852
8. Saharinen P., Bry M., Alitalo K., How do angiopoietins Tie in with vascular endothelial growth factors? Current Opinion in Hematology 2010 17 3 198 205
9. Kelly R. J., Darnell C., Rixe O., Target inhibition in antiangiogenic therapy a wide spectrum of selectivity and specificity Cancer Journal 2010 16 6 635 642
10. Beppu K., Jaboine J., Merchant M. S., Mackall C. L., Thiele C. J., Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression Journal of the National Cancer Institute 2004 96 1 46 55 (Pubitemid 38180959)
11. Fakhari M., Pullirsch D., Paya K., Abraham D., Hofbauer R., Aharinejad S., Upregulation of vascular endothelial growth factor receptors is associated with advanced neuroblastoma Journal of Pediatric Surgery 2002 37 4 582 587 (Pubitemid 34293096)
12. Langer I., Vertongen P., Perret J., Fontaine J., Atassi G., Robberecht P., Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas Medical and Pediatric Oncology 2000 34 6 386 393 (Pubitemid 30346403)
13. Das B., Yeger H., Tsuchida R., Torkin R., Gee M. F. W., Thorner P. S., Shibuya M., Malkin D., Baruchel S., A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1 through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma Cancer Research 2005 65 16 7267 7275 (Pubitemid 41161258)
14. Ribatti D., Marimpietri D., Pastorino F., Brignole C., Nico B., Vacca A., Ponzoni M., Angiogenesis in neuroblastoma Annals of the New York Academy of Sciences 2004 1028 133 142 (Pubitemid 40361817)
15. Brignole C., Marimpietri D., Pastorino F., Nico B., Di Paolo D., Cioni M., Piccardi F., Cilli M., Pezzolo A., Corrias M. V., Pistoia V., Ribatti D., Pagnan G., Ponzoni M., Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis Journal of the National Cancer Institute 2006 98 16 1142 1157 (Pubitemid 44288789)
16. Hamner J. B., Dickson P. V., Sims T. L., Zhou J., Spence Y., Ng C. Y., Davidoff A. M., Bortezomib inhibits angiogenesis and reduces tumor burden in a murine model of neuroblastoma Surgery 2007 142 2 185 191 (Pubitemid 47198675)
17. Segerstrm L., Fuchs D., Bckman U., Holmquist K., Christofferson R., Azarbayjani F., The anti-VEGF antibody bevacizumab potently reduces the growth rate of high-risk neuroblastoma xenografts Pediatric Research 2006 60 5 576 581 (Pubitemid 44627405)
18. Beaudry P., Nilsson M., Rioth M., Prox D., Poon D., Xu L., Zweidler-Mckay P., Ryan A., Folkman J., Ryeom S., Heymach J., Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium Molecular Cancer Therapeutics 2008 7 2 418 424 (Pubitemid 351302535)
19. Kim E. S., Serur A., Huang J., Manley C. A., McCrudden K. W., Frischer J. S., Soffer S. Z., Ring L., New T., Zabski S., Rudge J. S., Holash J., Yancopoulos G. D., Kandel J. J., Yamashiro D. J., Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma Proceedings of the National Academy of Sciences of the United States of America 2002 99 17 11399 11404 (Pubitemid 34920937)
20. Eggert A., Ikegaki N., Kwiatkowski J., Zhao H., Brodeur G. M., Himelstein B. P., High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas Clinical Cancer Research 2000 6 5 1900 1908 (Pubitemid 30305088)
21. Shimada A., Hirato J., Kuroiwa M., Kikuchi A., Hanada R., Wakai K., Hayashi Y., Expression of KIT and PDGFR is associated with a good prognosis in neuroblastoma Pediatric Blood and Cancer 2008 50 2 213 217
22. Funa K., hgren A., Characterization of platelet-derived growth factor (PDGF) action on a mouse neuroblastoma cell line, NB41, by introduction of an antisense PDGF/ -receptor RNA Cell Growth and Differentiation 1997 8 8 861 869 (Pubitemid 27355459)
23. Bckman U., Christofferson R., The selective class III/V receptor tyrosine kinase inhibitor SU11657 inhibits tumor growth and angiogenesis in experimental neuroblastomas grown in mice Pediatric Research 2005 57 5 I 690 695 (Pubitemid 40578040)
24. Cattaneo M. G., Scita G., Vicentini L. M., Somatostatin inhibits PDGF-stimulated Ras activation in human neuroblastoma cells FEBS Letters 1999 459 1 64 68 (Pubitemid 29447656)
25. Cohen P. S., Chan J. P., Lipkunskaya M., Biedler J. L., Seeger R. C., Expression of stem cell factor and c-kit in human neuroblastoma Blood 1994 84 10 3465 3472 (Pubitemid 24352911)
26. Timeus F., Ricotti E., Crescenzio N., Garelli E., Doria A., Spinelli M., Ramenghi U., Basso G., Flt-3 and its ligand are expressed in neural crest-derived tumors and promote survival and proliferation of their cell lines Laboratory Investigation 2001 81 7 1025 1037 (Pubitemid 32645978)
27. Vitali R., Cesi V., Nicotra M. R., McDowell H. P., Donfrancesco A., Mannarino O., Natali P. G., Raschell G., Dominici C., c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571 International Journal of Cancer 2003 106 2 147 152 (Pubitemid 36835164)
28. Strippoli P., Bagnara G. P., Montanaro L., Timeus F., Ferreri A. M., Rocchi P., Retinoic acid modulates stem cell factor secretion by human neuroblastoma cell lines Anticancer Research 2000 20 6 B 4361 4366 (Pubitemid 32141787)
29. Timeus F., Crescenzio N., Valle P., Pistamiglio P., Piglione M., Garelli E., Ricotti E., Rocchi P., Strippoli P., Di Montezemolo L. C., Madon E., Ramenghi U., Basso G., Stem cell factor suppresses apoptosis in neuroblastoma cell lines Experimental Hematology 1997 25 12 1253 1260 (Pubitemid 27508873)
30. Ara T., Fukuzawa M., Kusafuka T., Komoto Y., Oue T., Inoue M., Okada A., Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: association with tumor progression and clinical outcome Journal of Pediatric Surgery 1998 33 8 1272 1278
31. Chantrain C. F., Shimada H., Jodele S., Groshen S., Ye W., Shalinsky D. R., Werb Z., Coussens L. M., DeClerck Y. A., Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment Cancer Research 2004 64 5 1675 1686 (Pubitemid 38428689)
32. Pastorino F., Loi M., Sapra P., Becherini P., Cilli M., Emionite L., Ribatti D., Greenberger L. M., Horak I. D., Ponzoni M., Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor Clinical Cancer Research 2010 16 19 4809 4821
33. Sugiura Y., Shimada H., Seeger R. C., Laug W. E., DeClerck Y. A., Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis Cancer Research 1998 58 10 2209 2216 (Pubitemid 28232910)
34. Joshi S., Guleria R. S., Pan J., DiPette D., Singh U. S., Heterogeneity in retinoic acid signaling in neuroblastomas: role of matrix metalloproteinases in retinoic acid-induced differentiation Biochimica et Biophysica Acta 2007 1772 9 1093 1102 (Pubitemid 47314232)
35. Jodele S., Chantrain C. F., Blavier L., Lutzko C., Crooks G. M., Shimada H., Coussens L. M., DeClerck Y. A., The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinaae-9 dependent Cancer Research 2005 65 8 3200 3208 (Pubitemid 40524602)
36. Noujaim D., Van Golen C. M., Van Golen K. L., Grauman A., Feldman E. L., N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells Oncogene 2002 21 29 4549 4557 (Pubitemid 34785731)
37. Shusterman S., Maris J. M., Prospects for therapeutic inhibition of neuroblastoma angiogenesis Cancer Letters 2005 228 1-2 171 179 (Pubitemid 41188439)
38. Brodeur G. M., Neuroblastoma: biological insights into a clinical enigma Nature Reviews Cancer 2003 3 3 203 216 (Pubitemid 37328872)
39. Cetinkaya C., Hultquist A., Su Y., Wu S., Bahram F., Plman S., Guzhova I., Larsson L. G., Combined IFN- and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells Molecular Cancer Therapeutics 2007 6 10 2634 2641 (Pubitemid 350058144)
40. Gross N., Balmas K., Brognara C. B., Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells Cancer Research 1997 57 7 1387 1393 (Pubitemid 27152566)
41. Kang J., Rychahou P. G., Ishola T. A., Mourot J. M., Evers B. M., Chung D. H., N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma Oncogene 2008 27 28 3999 4007 (Pubitemid 351913633)
42. Pession A., Tonelli R., Fronza R., Sciamanna E., Corradini R., Sforza S., Tedeschi T., Marchelli R., Montanaro L., Camerin C., Franzoni M., Paolucci G., Targeted inhibition of NMYC by peptide nucleic acid in N-myc amplified human neuroblastoma cells: cell-cycle inhibition with induction of neuronal cell differentiation and apoptosis International Journal of Oncology 2004 24 2 265 272
43. Kang J. H., Rychahou P. G., Ishola T. A., Qiao J., Evers B. M., Chung D. H., MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells Biochemical and Biophysical Research Communications 2006 351 1 192 197 (Pubitemid 44635425)
44. Eggert A., Grotzer M. A., Ikegaki N., Liu X. G., Evans A. E., Brodeur G. M., Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells Cancer Research 2002 62 6 1802 1808 (Pubitemid 34408506)
45. Erdreich-Epstein A., Shimada H., Groshen S., Liu M., Metelitsa L. S., Kim K. S., Stins M. F., Seeger R. C., Durden D. L., Integrins (v) 3 and (v) 5 are expressed by endothelium of high- risk neuroblastoma and their inhibition is associated with increased endogenous ceramide Cancer Research 2000 60 3 712 721 (Pubitemid 30094572)
46. Strmblad S., Becker J. C., Yebra M., Brooks P. C., Cheresh D. A., Suppression of p53 activity and p21(WAF1/CIP1) expression by vascular cell integrin v 3 during angiogenesis Journal of Clinical Investigation 1996 98 2 426 433 (Pubitemid 26255742)
47. Joseph J. M., Gross N., Lassau N., Rouffiac V., Opolon P., Laudani L., Auderset K., Geay J. F., Mhlethaler-Mottet A., Vassal G., In vivo echographic evidence of tumoral vascularization and microenvironment interactions in metastatic orthotopic human neuroblastoma xenografts International Journal of Cancer 2005 113 6 881 890 (Pubitemid 40096867)
48. Senger D. R., Ledbetter S. R., Claffey K. P., Papadopoulos-Sergiou A., Perruzzi C. A., Detmar M., Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the (v) 3 integrin, osteopontin, and thrombin American Journal of Pathology 1996 149 1 293 305 (Pubitemid 26231000)
49. Hirama M., Takahashi F., Takahashi K., Akutagawa S., Shimizu K., Soma S., Shimanuki Y., Nishio K., Fukuchi Y., Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth Cancer Letters 2003 198 1 107 117 (Pubitemid 37289110)
50. Leali D., Dell'Era P., Stabile H., Sennino B., Chambers A. F., Naldini A., Sozzani S., Nico B., Ribatti D., Presta M., Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis Journal of Immunology 2003 171 2 1085 1093 (Pubitemid 36871426)
51. Hecht M., Schulte J. H., Eggert A., Wilting J., Schweigerer L., The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness Carcinogenesis 2005 26 12 2105 2115 (Pubitemid 41672198)
52. You W. K., McDonald D. M., The hepatocyte growth factor/c-met signaling pathway as a therapeutic target to inhibit angiogenesis Journal of Biochemistry and Molecular Biology 2008 41 12 833 839
53. Hecht M., Papoutsi M., Tran H. D., Wilting J., Schweigerer L., Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas Cancer Research 2004 64 17 6109 6118 (Pubitemid 39129411)
54. Ribatti D., Ponzoni M., Antiangiogenic strategies in neuroblastoma Cancer Treatment Reviews 2005 31 1 27 34 (Pubitemid 40246988)
55. Maris J. M., Courtright J., Houghton P. J., Morton C. L., Gorlick R., Kolb E. A., Lock R., Tajbakhsh M., Reynolds C. P., Keir S. T., Wu J., Smith M. A., Initial testing of the VEGFR inhibitor AZD2171 by the Pediatric Preclinical Testing Program Pediatric Blood and Cancer 2008 50 3 581 587 (Pubitemid 351155829)
56. Gomes E., Rockwell P., p38 MAPK as a negative regulator of VEGF/VEGFR2 signaling pathway in serum deprived human SK-N-SH neuroblastoma cells Neuroscience Letters 2008 431 2 95 100
57. Marimpietri D., Brignole C., Nico B., Pastorino F., Pezzolo A., Piccardi F., Cilli M., Di Paolo D., Pagnan G., Longo L., Perri P., Ribatti D., Ponzoni M., Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis Clinical Cancer Research 2007 13 13 3977 3988 (Pubitemid 47037606)
58. Sarker K. P., Biswas K. K., Yamaji K., Inhibition of thrombin-induced vascular endothelial growth factor production in human neuroblastoma (NB-1) cells by argatroban Pathophysiology of Haemostasis and Thrombosis 2005 34 1 41 47 (Pubitemid 41642804)
59. Kim E. S., Soffer S. Z., Huang J., McCrudden K. W., Yokoi A., Manley C. A., Middlesworth W., Kandel J. J., Yamashiro D. J., Distinct response of experimental neuroblastoma to combination antiangiogenic strategies Journal of Pediatric Surgery 2002 37 3 518 522 (Pubitemid 34188186)
60. Klement G., Baruchel S., Rak J., Man S., Clark K., Hicklin D. J., Bohlen P., Kerbel R. S., Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity Journal of Clinical Investigation 2000 105 8 R15 R24
61. Okuno M., Kojima S., Matsushima-Nishiwaki R., Tsurumi H., Muto Y., Friedman S. L., Moriwaki H., Retinoids in cancer chemoprevention Current Cancer Drug Targets 2004 4 3 285 298 (Pubitemid 38560076)
62. Haque A., Das A., Hajiaghamohseni L. M., Younger A., Banik N. L., Ray S. K., Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells Cancer Immunology, Immunotherapy 2007 56 5 615 625 (Pubitemid 46348732)
63. Kiningham K. K., Cardozo Z. A., Cook C., Cole M. P., Stewart J. C., Tassone M., Coleman M. C., Spitz D. R., All-trans-retinoic acid induces manganese superoxide dismutase in human neuroblastoma through NF- B Free Radical Biology and Medicine 2008 44 8 1610 1616
64. Messi E., Florian M. C., Caccia C., Zanisi M., Maggi R., Retinoic acid reduces human neuroblastoma cell migration and invasiveness: effects on DCX, LIS1, neurofilaments-68 and vimentin expression BMC Cancer 2008 8, article no. 30
65. Holback S., Adlerz L., Gatsinzi T., Jacobsen K. T., Iverfeldt K., PI3-K- and PKC-dependent up-regulation of APP processing enzymes by retinoic acid Biochemical and Biophysical Research Communications 2008 365 2 298 303 (Pubitemid 350137287)
66. Masi S., Alvarez S., De Lera A. R., Barettino D., Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor Molecular Endocrinology 2007 21 10 2391 2402 (Pubitemid 47529353)
67. De los Santos M., Zambrano A., Aranda A., Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells Molecular Cancer Therapeutics 2007 6 4 1425 1432 (Pubitemid 46712006)
68. Alique M., Herrero J. F., Lucio-Cazana F. J., All-trans retinoic acid induces COX-2 and prostaglandin E2 synthesis in SH-SY5Y human neuroblastoma cells: involvement of retinoic acid receptors and extracellular-regulated kinase 1/2 Journal of Neuroinflammation 2007 4 1 1 9
69. Jiang M., Zhu K., Grenet J., Lahti J. M., Retinoic acid induces caspase-8 transcription via phospho-CREB and increases apoptotic responses to death stimuli in neuroblastoma cells Biochimica et Biophysica Acta 2008 1783 6 1055 1067
70. Cuende J., Moreno S., Bolaos J. P., Almeida A., Retinoic acid downregulates Rae1 leading to APCCdh1 activation and neuroblastoma SH-SY5Y differentiation Oncogene 2008 27 23 3339 3344 (Pubitemid 351733387)
71. Wei J. S., Whiteford C. C., Cenacchi N., Chang G. S., Khan J., BBC3 mediates fenretinide-induced cell death in neuroblastoma Oncogene 2005 24 54 7976 7983 (Pubitemid 41746741)
72. Campbell Hewson Q. D., Lovat P. E., Corazzari M., Catterall J. B., Redfern C. P. F., The NF- B pathway mediates fenretinide-induced apoptosis in SH-SY5Y neuroblastoma cells Apoptosis 2005 10 3 493 498 (Pubitemid 40896655)
73. Casciano I., Banelli B., Croce M., De Ambrosis A., Di Vinci A., Gelvi I., Pagnan G., Brignole C., Allemanni G., Ferrini S., Ponzoni M., Romani M., Caspase-8 gene expression in neuroblastoma Annals of the New York Academy of Sciences 2004 1028 12 157 167 (Pubitemid 40361820)
74. Lovat P. E., Corazzari M., Goranov B., Piacentini M., Redfern C. P. F., Molecular mechanisms of fenretinide-induced apoptosis of neuroblastoma cells Annals of the New York Academy of Sciences 2004 1028 12 81 89 (Pubitemid 40361812)
75. Osone S., Hosoi H., Kuwahara Y., Matsumoto Y., Iehara T., Sugimoto T., Fenretinide induces sustained-activation of JNK/p38 MAPK and apoptosis in a reactive oxygen species-dependent manner in neuroblastoma cells International Journal of Cancer 2004 112 2 219 224 (Pubitemid 39244361)
76. Ribatti D., Alessandri G., Baronio M., Raffaghello L., Cosimo E., Marimpietri D., Montaldo P. G., De Falco G., Caruso A., Vacca A., Ponzoni M., Inhibition of neuroblastoma-induced angiogenesis by fenretinide International Journal of Cancer 2001 94 3 314 321 (Pubitemid 32906059)
77. Shusterman S., Grupp S. A., Barr R., Carpentieri D., Zhao H., Maris J. M., The angiogenesis inhibitor TNP-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease Clinical Cancer Research 2001 7 4 977 984 (Pubitemid 32708737)
78. Yasuda C., Sakata S., Kakinoki S., Takeyama Y., Ohyanagi H., Shiozaki H., In vivo evaluation of microspheres containing the angiogenesis inhibitor, TNP-470, and the metastasis suppression with liver metastatic model implanted neuroblastoma Pathophysiology 2010 17 2 149 155
79. Morowitz M. J., Barr R., Wang Q., King R., Rhodin N., Pawel B., Zhao H., Erickson S. A., Sheppard G. S., Wang J., Maris J. M., Shusterman S., Methionine aminopeptidase 2 inhibition is an effective treatment strategy for neuroblastoma in preclinical models Clinical Cancer Research 2005 11 7 2680 2685 (Pubitemid 40569469)
80. Wang J., Sheppard G. S., Lou P., Kawai M., BaMaung N., Erickson S. A., Tucker-Garcia L., Park C., Bouska J., Wang Y. C., Frost D., Tapang P., Albert D. H., Morgan S. J., Morowitz M., Shusterman S., Maris J. M., Lesniewski R., Henkin J., Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2 Cancer Research 2003 63 22 7861 7869 (Pubitemid 37466720)
81. Wang J., Tucker L. A., Stavropoulos J., Zhang Q., Wang Y. C., Bukofzer G., Niquette A., Meulbroek J. A., Barnes D. M., Shen J., Bouska J., Donawho C., Sheppard G. S., Bell R. L., Correlation of tumor growth suppression and methionine aminopetidase-2 activity blockade using an orally active inhibitor Proceedings of the National Academy of Sciences of the United States of America 2008 105 6 1838 1843 (Pubitemid 351439426)
82. Kuroiwa M., Ikeda H., Hongo T., Tsuchida Y., Hirato J., Kaneko Y., Suzuki N., Obana K., Makino S. I., Effects of recombinant human endostatin on a human neuroblastoma xenograft International Journal of Molecular Medicine 2001 8 4 391 396
83. Streck C., Zhang Y., Zhou J., Ng C. Y. C., Davidoff A. M., LaQuaglia M., Ziegler M., Nuchtern J., Endostatin-mediated concomitant resistance in neuroblastoma Journal of Pediatric Surgery 2004 39 3 405 411 (Pubitemid 38338358)
84. Yap T. A., De Bono J. S., Targeting the HGF/c-met axis: state of play Molecular Cancer Therapeutics 2010 9 5 1077 1079
85. Crosswell H. E., Dasgupta A., Alvarado C. S., Watt T., Christensen J. G., De P., Durden D. L., Findley H. W., PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells BMC Cancer 2009 9 11, article 411
86. Kuljaca S., Liu T., Tee A. E. L., Haber M., Norris M. D., Dwarte T., Marshall G. M., Enhancing the anti-angiogenic action of histone deacetylase inhibitors Molecular Cancer 2007 6 10, article 68
87. Zhang L., Smith K. M., Chong A. L., Stempak D., Yeger H., Marrano P., Thorner P. S., Irwin M. S., Kaplan D. R., Baruchel S., In vivo antitumor and antimetastatic activity of Sunitinib in preclinical Neuroblastoma mouse model Neoplasia 2009 11 5 426 435
88. Dickson P. V., Hamner J. B., Sims T. L., Fraga C. H., Ng C. Y. C., Rajasekeran S., Hagedorn N. L., McCarville M. B., Stewart C. F., Davidoff A. M., Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy Clinical Cancer Research 2007 13 13 3942 3950 (Pubitemid 47037602)
89. Yang Q., Tian Y., Liu S., Zeine R., Chlenski A., Salwen H. R., Henkin J., Cohn S. L., Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma Cancer Research 2007 67 4 1716 1724 (Pubitemid 46383398)
90. Pagnan G., Paolo D. D., Carosio R., Pastorino F., Marimpietri D., Brignole C., Pezzolo A., Loi M., Galietta L. J. V., Piccardi F., Cilli M., Nico B., Ribatti D., Pistoia V., Ponzoni M., The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response Clinical Cancer Research 2009 15 4 1199 1209
91. Gong H., Pttgen C., Stben G., Havers W., Stuschke M., Schweigerer L., Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: potentiation by irradiation International Journal of Cancer 2003 106 5 723 728 (Pubitemid 36993396)
92. Cinatl J. Jr., Kotchetkov R., Blaheta R., Driever P. H., Vogel J. U., Cinatl J., Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha International Journal of Oncology 2002 20 1 97 106
93. Spurbeck W. W., Ng C. Y. C., Vanin E. F., Davidoff A. M., Retroviral vector-producer cell-mediated in vivo gene transfer of TIMP-3 restricts angiogenesis and neuroblastoma growth in mice Cancer Gene Therapy 2003 10 3 161 167 (Pubitemid 36348676)
94. Davidoff A. M., Leary M. A., Ng C. Y. C., Vanin E. F., Gene therapy-mediated expression by tumor cells of the angiogenesis inhibitor flk-1 results in inhibition of neuroblastoma growth in vivo Journal of Pediatric Surgery 2001 36 1 30 36 (Pubitemid 32044311)
95. Streck C. J., Dickson P. V., Ng C. Y. C., Zhou J., Gray J. T., Nathwani A. C., Davidoff A. M., Adeno-associated virus vector-mediated systemic delivery of IFN- combined with low-dose cyclophosphamide affects tumor regression in murine neuroblastoma models Clinical Cancer Research 2005 11 16 6020 6029 (Pubitemid 41170334)
96. Ino Y., Saeki Y., Fukuhara H., Todo T., Triple combination of oncolytic herpes simplex virus-1 vectors armed with interleukin-12, interleukin-18, or soluble B7-1 results in enhanced antitumor efficacy Clinical Cancer Research 2006 12 2 643 652 (Pubitemid 43166160)
97. Siapati K. E., Barker S., Kinnon C., Michalski A., Anderson R., Brickell P., Thrasher A. J., Hart S. L., Improved antitumour immunity in murine neuroblastoma using a combination of IL-2 and IL-12 British Journal of Cancer 2003 88 10 1641 1648 (Pubitemid 36713794)
98. Croce M., Meazza R., Orengo A. M., Radic L., De Giovanni B., Gambini C., Carlini B., Pistoia V., Mortara L., Accolla R. S., Corrias M. V., Ferrini S., Sequential immunogene therapy with interleukin-12- and interleukin-15- engineered neuroblastoma cells cures metastatic disease in syngeneic mice Clinical Cancer Research 2005 11 2 I 735 742 (Pubitemid 40116902)
99. Lode H. N., Moehler T., Xiang R., Jonczyk A., Gillies S. D., Cheresh D. A., Reisfeld R. A., Synergy between an antiangiogenic integrin v antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases Proceedings of the National Academy of Sciences of the United States of America 1999 96 4 1591 1596 (Pubitemid 29098496)
100. Pastorino F., Brignole C., Di Paolo D., Nico B., Pezzolo A., Marimpietri D., Pagnan G., Piccardi F., Cilli M., Longhi R., Ribatti D., Corti A., Allen T. M., Ponzoni M., Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy Cancer Research 2006 66 20 10073 10082 (Pubitemid 44672061)
101. Corti A., Ponzoni M., Tumor vascular targeting with tumor necrosis factor and chemotherapeutic drugs Annals of the New York Academy of Sciences 2004 1028 104 112 (Pubitemid 40361814)
102. Burrows F. J., Overholser J. P., Thorpe P. E., Potent antitumor effects of an antitumor endothelial cell immunotoxin in a murine vascular targeting model Cell Biophysics 1994 24-25 1-3 15 25
103. Roy Choudhury S., Karmakar S., Banik N. L., Ray S. K., Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplification Investigational New Drugs 2010 28 6 812 824
104. Palmberg E., Johnsen J. I., Paulsson J., Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo International Journal of Cancer 2009 124 5 1227 1234